Pacifica Partners
MRNA icon

Pacifica Partners’s Moderna MRNA Stock Holding History

Pacifica Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$94.4K Hold
500
– – 0.03% 156
2026
Q2 		$39.9K Hold
500
– – 0.01% 202
2026
Q1 		$25.4K Hold
500
– – 0.01% 241
2025
Q4 		$15.4K Hold
500
– – 0.01% 267
2025
Q3 		$13.8K Buy
500
+450
+900% +$12.6K ﹤0.01% 299
2025
Q2 		$1.36K Hold
50
– – ﹤0.01% 491
2025
Q1 		$1.29K Sell
50
-100
-67% -$3.55K ﹤0.01% 474
2024
Q4 		$6.3K Sell
150
-30
-17% -$1.43K ﹤0.01% 360
2024
Q3 		$12K Hold
180
– – 0.01% 341
2024
Q2 		$20.9K Buy
180
+30
+20% +$3.8K 0.01% 295
2024
Q1 		$16.5K Sell
150
-50
-25% -$5.04K 0.01% 313
2023
Q4 		$15.7K Hold
200
– – 0.01% 325
2023
Q3 		$20.6K Buy
200
+150
+300% +$16.7K 0.01% 282
2023
Q2 		$6.18K Sell
50
-15
-23% -$2K ﹤0.01% 349
2023
Q1 		$10.2K Buy
65
+15
+30% +$2.48K 0.01% 305
2022
Q4 		$9.02K Hold
50
– – 0.01% 293
2022
Q3 		$7K Buy
50
+20
+67% +$3.04K 0.01% 334
2022
Q2 		$4K Buy
+30
New +$4.29K ﹤0.01% 392

Other funds holding MRNA

Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures, LLc
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Pacifica Partners's MRNA Position: Q3 2026 in Review

Pacifica Partners held its Moderna (MRNA) position steady in Q3 2026 at 500 shares worth $94.4K. The position accounts for 0.03% of the portfolio, ranked #156.

Pacifica Partners first reported a position in MRNA in Q2 2022 and has held it in 18 quarters since. 221 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Pacifica Partners held 500 shares of Moderna worth $94.4K as of Q3 2026.
  • Pacifica Partners left its Moderna share count unchanged in Q3 2026.
  • Moderna made up 0.03% of Pacifica Partners's portfolio in Q3 2026, its #156 holding.
  • Pacifica Partners first reported a position in Moderna in Q2 2022 and has held it in 18 quarters since.
  • 221 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Pacifica Partners's 13F filing for Q3 2026, filed 9 Oct 2026.